VNA
PTX

Valley National Advisers’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Valley National Advisers’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-6
Closed – – 859
2018
Q4 		$0 Hold
6
– – ﹤0.01% 868
2018
Q3 		$0 Hold
6
– – ﹤0.01% 779
2018
Q2 		$0 Hold
6
– – ﹤0.01% 747
2018
Q1 		$0 Hold
6
– – ﹤0.01% 734
2017
Q4 		$0 Hold
6
– – ﹤0.01% 753
2017
Q3 		$0 Buy
+6
New +$19 ﹤0.01% 732

Valley National Advisers's PTX Position: Q1 2019 in Review

Valley National Advisers sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q1 2019, closing a stake of 6 shares.

Valley National Advisers first reported a position in PTX in Q3 2017 and held it in 6 quarters. The position peaked at $0 in Q4 2018. 1 fund tracked by Wall St. Rank holds PTX as of Q1 2019.

  • Valley National Advisers reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q1 2019 after selling out during the quarter.
  • Valley National Advisers sold 6 Pernix Therapeutics Holdings, Inc. shares in Q1 2019.
  • Valley National Advisers first reported a position in Pernix Therapeutics Holdings, Inc. in Q3 2017 and held it in 6 quarters.
  • Valley National Advisers's Pernix Therapeutics Holdings, Inc. position peaked at $0 in Q4 2018.
  • 1 fund tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q1 2019.

Based on Valley National Advisers's 13F filing for Q1 2019, filed 26 Apr 2019.